文献

J-GLOBAL ID：202202256054986560   整理番号：22A1150174

Pfizer/BioNTech BNT162b2ワクチン接種後のSARS-CoV-2スパイク蛋白に対するIgG抗体価のピーク

Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine

著者 (13件)： Kobashi Yurie (Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District) ,  Kobashi Yurie (Department of Radiation Health Management, Fukushima Medical University School of Medicine) ,  Shimazu Yuzo (Department of Radiation Health Management, Fukushima Medical University School of Medicine) ,  Shimazu Yuzo (Southern Tohoku Research Institute for Neuroscience) ,  Kawamura Takeshi (Proteomics Laboratory, Isotope Science Center, The University of Tokyo) ,  Kawamura Takeshi (Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo) ,  Nishikawa Yoshitaka (Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District) ,  Omata Fumiya (Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District) ,  Kaneko Yudai (Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo) ,  Kaneko Yudai (Medical & Biological Laboratories Co., Ltd.) ,  Kodama Tatsuhiko (Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo) ,  Tsubokura Masaharu (Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District) ,  Tsubokura Masaharu (Department of Radiation Health Management, Fukushima Medical University School of Medicine)
資料名： Fukushima Journal of Medical Science (Web)  (Fukushima Journal of Medical Science (Web))
巻： 68  号： 1  ページ： 67-70(J-STAGE)  発行年： 2022年 
JST資料番号： U0218A  ISSN： 2185-4610  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 本研究では,日本の福島県の病院における職員12名を対象に,B...

シソーラス用語： ヒト ,...
準シソーラス用語： COVID-19 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1150174&from=J-GLOBAL&jstjournalNo=U0218A") }}

著者キーワード (3件)： SARS-CoV-2スパイク蛋白質に対するIgG抗体 ,  BNT162b2ワクチン接種 ,  COVID-19

分類 (2件)： 免疫療法薬・血液製剤の臨床への応用  (GW22020O) ,  感染症・寄生虫症一般  (GD01010H)

引用文献 (5件)：

• 1 Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN):a prospective, multicentre, cohort study. Lancet, 397(10286):1725-1735, 2021.
• 2 Angel Y, Spitzer A, Henig O, et al. Association between vaccination With BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. JAMA, 325(24):2457-2465, 2021.
• 3 Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA, 325(21):2204-2206, 2021.
• 4 Terpos E, Trougakos IP, Apostolakou F, et al. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Am J Hematol, 96(7):E257-E259, 2021.
• 5 Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med, published online Jun 23, 2021. doi:10.1056/NEJMc2108861.

タイトルに関連する用語 (6件)： ワクチン接種 ,  SARS-CoV-2 ,  スパイク ,  蛋白 ,  IgG ,  抗体価